Form 8-K - Current report:
SEC Accession No. 0001193125-21-247691
Filing Date
2021-08-16
Accepted
2021-08-16 16:04:02
Documents
13
Period of Report
2021-08-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d193376d8k.htm   iXBRL 8-K 25639
2 EX-10.1 d193376dex101.htm EX-10.1 25880
  Complete submission text file 0001193125-21-247691.txt   183278

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210815.xsd EX-101.SCH 2924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210815_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210815_pre.xml EX-101.PRE 11429
6 EXTRACTED XBRL INSTANCE DOCUMENT d193376d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211177830
SIC: 2834 Pharmaceutical Preparations